Pathological implications of cell cycle re-entry in Alzheimer disease.

MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons. J Neurosci (2013) 1.07

Functions of FUS/TLS from DNA repair to stress response: implications for ALS. ASN Neuro (2014) 0.95

Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function. Genes Cancer (2012) 0.93

Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice. BMC Neurosci (2013) 0.92

Molecular network analysis of human microRNA targetome: from cancers to Alzheimer's disease. BioData Min (2012) 0.91

Brain site-specific proteome changes in aging-related dementia. Exp Mol Med (2013) 0.87

Dragon exploration system on marine sponge compounds interactions. J Cheminform (2013) 0.81

Differential network analyses of Alzheimer's disease identify early events in Alzheimer's disease pathology. Int J Alzheimers Dis (2014) 0.77

Amyloid Precursor Protein Binding Protein-1 Is Up-regulated in Brains of Tg2576 Mice. Korean J Physiol Pharmacol (2010) 0.77

The Ticking of the Epigenetic Clock: Antipsychotic Drugs in Old Age. Front Endocrinol (Lausanne) (2016) 0.75

Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease. Acta Neuropathol Commun (2017) 0.75

G1 phase progression: cycling on cue. Cell (1994) 11.62

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A (1986) 10.13

MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res (2009) 4.32

Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene (1995) 3.96

Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition. Acta Neuropathol (1984) 2.97

DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci (2001) 2.60

Mitotic mechanisms in Alzheimer's disease? J Cell Biol (1996) 2.00

Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci (1997) 2.00

Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing. J Cell Biol (2001) 1.86

Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol (1997) 1.84

Alzheimer's disease: the two-hit hypothesis. Lancet Neurol (2004) 1.81

The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron (1992) 1.72

Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol (1997) 1.71

Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol (1999) 1.69

Apoptosis and the cell cycle. J Cell Biochem (1995) 1.60

Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models. J Neurosci (2006) 1.60

Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell (1997) 1.60

Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol (1997) 1.58

Alzheimer disease, the two-hit hypothesis: an update. Biochim Biophys Acta (2006) 1.56

Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease. J Neurosci (2007) 1.52

Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis. Mech Ageing Dev (2001) 1.47

Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice. Proc Natl Acad Sci U S A (1992) 1.44

Alzheimer disease. Int Rev Neurobiol (1998) 1.43

A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage. J Neurosci (2002) 1.37

Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice. Neuron (1992) 1.36

Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J Neuropathol Exp Neurol (2000) 1.31

Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death. J Biol Chem (1999) 1.30

Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS Neurol Disord Drug Targets (2007) 1.24

Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe? Acta Neuropathol (2003) 1.24

Abeta oligomers induce neuronal cell cycle events in Alzheimer's disease. J Neurosci (2008) 1.23

NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease. J Clin Invest (2009) 1.23

Cell cycle regulators in neuronal death evoked by excitotoxic stress: implications for neurodegeneration and its treatment. Neurobiol Aging (2001) 1.22

Mitotic signaling by beta-amyloid causes neuronal death. FASEB J (1999) 1.21

Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. Biochim Biophys Acta (2006) 1.19

Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons. Neuroscience (1994) 1.15

Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurol Disord Drug Targets (2008) 1.15

Conditional neuronal simian virus 40 T antigen expression induces Alzheimer-like tau and amyloid pathology in mice. J Neurosci (2007) 1.14

The Alzheimer amyloid precursor protein maps to human chromosome 21 bands q21.105-q21.05. Genomics (1989) 1.10

The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. Am J Pathol (2009) 1.08

Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. Free Radic Biol Med (2001) 1.06

Apoptosis and Alzheimer's disease. Science (1998) 1.06

Neuronal binucleation in Alzheimer disease hippocampus. Neuropathol Appl Neurobiol (2007) 1.05

Oxidative imbalance in Alzheimer's disease. Mol Neurobiol (2005) 1.05

Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease. J Neurosci Res (2004) 1.03

The cell cycle hypothesis of Alzheimer's disease: suggestions for drug development. Biochim Biophys Acta (2006) 1.02

Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. J Neuropathol Exp Neurol (1995) 1.01

Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease. Aging (Albany NY) (2009) 1.01

Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease. Med Hypotheses (1999) 1.00

Distribution, levels, and activation of MEK1 in Alzheimer's disease. J Neurochem (2003) 0.98

Apoptosis in Alzheimer disease: a mathematical improbability. Curr Alzheimer Res (2006) 0.98

BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease. Int J Med Sci (2007) 0.97

Comparison of Abeta levels in the brain of familial and sporadic Alzheimer's disease. Neurochem Int (2009) 0.96

The relationship of tamoxifen with dementia, depression, and dependence in activities of daily living in elderly nursing home residents. Women Health (2000) 0.93

The role of microglia in antibody-mediated clearance of amyloid-beta from the brain. CNS Neurol Disord Drug Targets (2009) 0.92

Iron, neuroinflammation, and Alzheimer's disease. J Alzheimers Dis (2005) 0.89

Presenilin overexpression arrests cells in the G1 phase of the cell cycle. Arrest potentiated by the Alzheimer's disease PS2(N141I)mutant. Am J Pathol (1999) 0.88

Cell cycle events in neurons. Proliferation or death? Am J Pathol (1999) 0.88

Increased expression of p130 in Alzheimer disease. Neurochem Res (2006) 0.87

Dysfunction of amyloid precursor protein signaling in neurons leads to DNA synthesis and apoptosis. Biochim Biophys Acta (2006) 0.87

Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease. Int J Clin Exp Pathol (2008) 0.87

Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration. Neuroscience (1999) 0.86

Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Neuropathol Appl Neurobiol (2001) 0.85

Amyloid beta protein precursor is a mitogen. Biochem Biophys Res Commun (1989) 0.85

Premature centromere division of the X chromosome in neurons in Alzheimer's disease. J Neurochem (2008) 0.83

Immunological demonstration of tau protein in neurofibrillary tangles of Alzheimer's disease. J Alzheimers Dis (2006) 0.83

Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest. Neurobiol Aging (2001) 0.82

Mitochondrial abnormalities and oxidative imbalance in neurodegenerative disease. Sci Aging Knowledge Environ (2002) 0.81

Presenilin 1 overexpressions in Chinese hamster ovary (CHO) cells decreases the phosphorylation of retinoblastoma protein: relevance for neurodegeneration. Neurosci Lett (2002) 0.81

Neuroinflammatory changes increase the impact of stressors on neuronal function. Biochem Soc Trans (2009) 0.79

[Genetics and Alzheimer's disease]. Neurologia (2009) 0.77

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Comparative genome sequencing of Drosophila pseudoobscura: chromosomal, gene, and cis-element evolution. Genome Res (2005) 8.38

Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci (2009) 3.77

Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A (2008) 3.68

AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J Clin Invest (2007) 3.32

The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J Clin Invest (2005) 2.40

Oxidative stress and neurotoxicity. Chem Res Toxicol (2007) 2.12

Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates. PLoS Pathog (2008) 2.10

Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. Am J Pathol (2008) 2.09

Neural circuit involved in idiopathic infantile nystagmus syndrome based on FMRI. J Pediatr Ophthalmol Strabismus (2011) 2.02

Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta. Brain Res Brain Res Rev (2003) 1.97

Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol (2006) 1.92

Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry (2003) 1.89

Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis (2002) 1.85

Alzheimer's disease: the two-hit hypothesis. Lancet Neurol (2004) 1.81

Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion. Prog Neurobiol (2011) 1.80

A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression. Biol Psychiatry (2012) 1.76

Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: evidence for Abeta(25-35). Exp Neurol (2009) 1.75

Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic Biol Med (2012) 1.67

The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J Neurochem (2009) 1.67

Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. Biochim Biophys Acta (2009) 1.66

Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. Am J Pathol (2003) 1.66

Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem (2002) 1.65

Alzheimer disease. Dis Mon (2010) 1.64

Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. J Biol Chem (2005) 1.61

Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. J Neurochem (2007) 1.61

Dominant role of the p110beta isoform of PI3K over p110alpha in energy homeostasis regulation by POMC and AgRP neurons. Cell Metab (2009) 1.59

Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. J Neurochem (2011) 1.57

The role of mitogen-activated protein kinase pathways in Alzheimer's disease. Neurosignals (2003) 1.56

LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum Mol Genet (2012) 1.56

Alzheimer disease, the two-hit hypothesis: an update. Biochim Biophys Acta (2006) 1.56

A new model of oxidative stress in rat pups. Neonatology (2008) 1.55

Impaired regulation of synaptic strength in hippocampal neurons from GluR1-deficient mice. J Physiol (2003) 1.55

Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. PLoS One (2010) 1.54

The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules. J Neurosci Res (2008) 1.54

Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimers Dis (2010) 1.54

Chitin-like polysaccharides in Alzheimer's disease brains. Curr Alzheimer Res (2005) 1.51

Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim Biophys Acta (2009) 1.49

Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease. Ann N Y Acad Sci (2004) 1.49

Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. FASEB J (2002) 1.47

Cell cycle proteins in Alzheimer's disease: plenty of wheels but no cycle. J Alzheimers Dis (2002) 1.47

Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability. Proc Natl Acad Sci U S A (2003) 1.46

4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal. Chem Res Toxicol (2005) 1.46

Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology (2010) 1.46

Nucleic acid oxidation in Alzheimer disease. Free Radic Biol Med (2008) 1.45

Alzheimer disease pathology as a host response. J Neuropathol Exp Neurol (2008) 1.45

Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice. J Nucl Med (2002) 1.44

The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha. J Neurochem (2009) 1.43

Leptin: a novel therapeutic strategy for Alzheimer's disease. J Alzheimers Dis (2009) 1.42

Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans: effects of dopaminergic modulation. Biol Psychiatry (2007) 1.39

Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death. Hum Mol Genet (2011) 1.38

Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res (2002) 1.37

Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage. Invest Ophthalmol Vis Sci (2007) 1.37

Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease. J Alzheimers Dis (2010) 1.37

Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic Biol Med (2002) 1.34

Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiol Dis (2002) 1.34

Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice. Brain Res (2004) 1.34

Oxidative stress signalling in Alzheimer's disease. Brain Res (2004) 1.33

Neuropathology of Alzheimer disease: pathognomonic but not pathogenic. Acta Neuropathol (2006) 1.33

NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proc Natl Acad Sci U S A (2012) 1.32

Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells. Biochem Biophys Res Commun (2008) 1.31

Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta. Biochemistry (2004) 1.30

The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathol (2002) 1.29

Oxidative stress in diabetes and Alzheimer's disease. J Alzheimers Dis (2009) 1.29

eIF2alpha phosphorylation tips the balance to apoptosis during osmotic stress. J Biol Chem (2010) 1.28

Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons. Neurodegener Dis (2010) 1.27

Tau--an inhibitor of deacetylase HDAC6 function. J Neurochem (2009) 1.27

The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations. Lancet Neurol (2011) 1.27

Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochim Biophys Acta (2006) 1.26

Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta (2009) 1.25